John Lister-James
National Heart Foundation of Australia
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by John Lister-James.
The Journal of Clinical Pharmacology | 1993
Ruth Hardoff; Frank Braegelmann; Pat Zanzonico; Edmund M. Herrold; Robert S. Lees; Ann M. Lees; Richard T. Dean; John Lister-James; Jeffrey S. Borer
The oligopeptide fragment of apolipoprotein B, SP‐4, has demonstrated pronounced uptake in the healing edges of balloon‐injured rabbit aortic endothelium. To assess 123I‐labeled SP‐4 for identification of atherosclerotic plaques by gamma camera imaging, 14 Watanabe heritable hyperlipidemic (WHHL) and 5 normal rabbits were imaged 5 minutes and 12 and 24 hours after intravenous injection of123I‐SP‐4. In addition, two WHHL and two normal rabbits were injected with 125I‐SP‐4 for autoradiography. Twelve of the 14 WHHL, but none of the normal, rabbits had visually apparent focal radioiodine accumulation in the region of the aorta. Focus‐to‐lung and focus‐to‐heart count ratios were 2.4 ± 1.3 and 1.0 ± 0.4, respectively. Five of the visually positive WHHL rabbits were reimaged 4 and 8 weeks later with 123I‐NaI and 123I‐SP‐2 (an apo E peptide), respectively, as negative controls. Perceptible, but faint, aortic localization of 123I‐NaI and of 123I‐SP‐2 was seen in only one animal each. The distributions of atherosclerotic lesions on photographs of the opened WHHL aortas and of film blackening on 125I‐SP‐4 autoradiograms were identical. In contrast, the two normal rabbit aortas did not exhibit plaques on photographs or film blackening on autoradiograms. Thus, in an animal model closely simulating human atherosclerotic disease, SP‐4 localizes specifically in aortic atherosclerotic lesions.
The Journal of Nuclear Medicine | 1996
Shankar Vallabhajosula; Brian R. Moyer; John Lister-James; Bill McBride; Helena Lipszyc; Hiram Lee; Diago Bastidas; R. T. Dean
JAMA Internal Medicine | 2003
Shannon M. Bates; John Lister-James; Jim A. Julian; Raymond Taillefer; Brian R. Moyer; Jeffrey S. Ginsberg
Bioconjugate Chemistry | 1990
Robert W. Weber; Raymond H. Boutin; Mark A. Nedelman; John Lister-James; Richard T. Dean
The Journal of Nuclear Medicine | 1996
Brian R. Moyer; Shankar Vallabhajosula; John Lister-James; Larry R. Bush; John E. Cyr; Debra A. Snow; Diego Bastidas; Helena Lipszyc; R. T. Dean
The Journal of Nuclear Medicine | 1997
John Lister-James; Shankar Vallabhajosula; Brian R. Moyer; Daniel A. Pearson; Bill McBride; Mark A. De Rosch; Larry R. Bush; Josef Machac; R. T. Dean
Nuclear Medicine Communications | 2000
C. A. Nelson; I. Virgolini; Daniel A. Pearson; D. M. Wilson; W. B. Jones; J. E. Cyr; John Lister-James; R. T. Dean
Nuclear Medicine Communications | 2000
C. A. Nelson; Brian R. Moyer; Daniel A. Pearson; R. Manchanda; D. M. Wilson; J. V. Rutkowski; John Lister-James; R. T. Dean
Nuclear Medicine Communications | 2000
R. Manchanda; M. T. Azure; Daniel A. Pearson; D. M. Wilson; Brian R. Moyer; C. A. Nelson; J. E. Cyr; M. A. De Rosch; W. B. Jones; Y. Baran; John Lister-James; R. T. Dean
Nuclear Medicine Communications | 2000
Brian R. Moyer; R. Manchanda; Daniel A. Pearson; J. E. Cyr; E. J. Little; John Lister-James; R. T. Dean